May in tweets

Last month we were diligently completing the primary screening phase of our NPC campaign: 50,000 compounds across 3 models in 6 months. Our NPC worm screen is nearing the home stretch. pic.twitter.com/eBOTpUq1N9 — Perlstein Lab PBC (@PerlsteinLab) May 1, 2015...
Perlstein Lab Burn Rate 2015 (Q1-Q2+May)

Perlstein Lab Burn Rate 2015 (Q1-Q2+May)

Previously, we highlighted Perlstein Lab’s burn rate from 2014. We’ll revisit that post and discuss our expenses for January through May 2015. We aim to give guidance to new entrepreneurs and ideas to existing biotech companies. We may not make the best decisions, but...
Biologics and you

Biologics and you

This post is written by Kiran Singh, Data Guru @PLab. In our last post we talked specifically about orphan drugs that are small molecules. In this post I’ll address the orphan drugs that are biologics. They behave differently: There’s a possible increase in...
Orphan drug prices and approvals

Orphan drug prices and approvals

This post is written by Kiran Singh, Data Guru @PLab. This post kicks off a series about drug prices in the orphan drug space. We initially wanted to get a sense of orphan drug price trends over the last 30 years — since the passage of the Orphan Drug Act of...
Translate »